|
Market Cap (2-Jul) $147,983,008 (477th) |
Close (30-Jun) $0.99 |
Volume (30-Jun) 1,077,429 |
Shortsold (19-Jun) 1,473,254 (0.38%) (338th) |
|
52w High $0.66 |
52w Low $0.165 |
P/E - |
EPS -0.05 |
PAR released this announcement to the ASX on 15 August 2022, 9:01. The announcement is not marked as price sensitive, and is 11 page(s) in length and 38.62kb in size.
You can view all announcements from PAR and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAR was 3.809% short sold according to ASIC data. It was ranked the 58th most shorted stock on the ASX. It remains ranked 338th as of the latest reported data (19 June 2025).
| Other Recent Announcements from PAR | |
|---|---|
| Notification of cessation of securities - PAR | 29 June 2023, 16:43 |
| Primary and Secondary endpoints met in MPS I Trial | 6 June 2023, 12:28 |
| iPPS shows 3-year equivalent durability in OA Canine Study | 1 June 2023, 8:21 |
| Proposed issue of securities - PAR | 15 August 2022, 9:01 |
| Investor Presentation - $66m Capital Raise | 15 August 2022, 9:00 |
| Paradigm Launches $66M Capital Raising | 15 August 2022, 8:59 |
| Trading Halt | 11 August 2022, 9:35 |
You must be logged in to post a reply.
Paradigm Biopharmaceuticals 